Page last updated: 2024-10-31

midazolam and Ovarian Neoplasms

midazolam has been researched along with Ovarian Neoplasms in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Weichselbaumer, E1
Weixler, D1

Other Studies

1 other study available for midazolam and Ovarian Neoplasms

ArticleYear
[Palliative sedation for psycho-existential suffering].
    Wiener medizinische Wochenschrift (1946), 2014, Volume: 164, Issue:9-10

    Topics: Attitude to Death; Austria; Caregivers; Conscious Sedation; Ethics, Medical; Existentialism; Female;

2014